Morningstar

Morningstar, Inc.

Equity Bottom-Up

We are dropping coverage of Mallinckrodt. We provide broad coverage of more than 1,500 companies globally and periodically adjust our coverage according to investor interest and staffing.

<p>We are placing Mallinckrodt under review as we transfer coverage to a new analyst. We expect to publish a new fair value estimate in the second quarter.</p>

United States

Mallinckrodt PLC develops, manufactures and markets specialty pharmaceutical products and diagnostic imaging agents. The Company specializes in the manufacturing of pain management medications. Mallinckrodt offers its products to major wholesalers and retail drug store chains around the world.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00